Medmira Inc. Stock
Your prediction
Medmira Inc. Stock
A very strong showing by Medmira Inc. today, with an increase of €0.005 (15.380%) compared to yesterday's price.
Pros and Cons of Medmira Inc. in the next few years
Pros
?
S********** s********
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
B****
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Medmira Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Medmira Inc. | 15.380% | -13.333% | -20.732% | -35.000% | -59.375% | -18.750% | - |
| Theralase Technologies Inc | 1.160% | -0.588% | -21.028% | -48.788% | -47.188% | -60.514% | -33.465% |
| Atossa Genetics Inc | 5.190% | 15.276% | 1.105% | -38.591% | -24.224% | 16.080% | 0.771% |
| Aortech International plc | 3.590% | 0.000% | -10.550% | 0.000% | -12.946% | -72.765% | -94.522% |
News
Health Canada approves MedMira’s Reveal® Rapid TP Test - Urgent New Tool In The Battle Against Syphilis
Halifax, Nova Scotia, 26 August 2025 – MedMira Inc. (MedMira) (TSXV: MIR) announced today that it has received approval from Health Canada for its Reveal® TP (Syphilis) Antibody Test (Reveal®
MedMira Announces Launch of Clinical Trial for Its Multiplo® TP/HIV Self-Test in Canada
Halifax, Nova Scotia, July 7, 2025 – MedMira Inc. (MedMira) (TSXV: MIR) and REACH Nexus are excited to announce a clinical trial has officially started earlier than anticipated to evaluate